Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Neutropenia in Patients with Common Variable Immunodeficiency: a Rare Event Associated with Severe Outcome.

Guffroy A, Mourot-Cottet R, Gérard L, Gies V, Lagresle C, Pouliet A, Nitschké P, Hanein S, Bienvenu B, Chanet V, Donadieu J, Gardembas M, Karmochkine M, Nove-Josserand R, Martin T, Poindron V, Soulas-Sprauel P, Rieux-Laucat F, Fieschi C, Oksenhendler E, André-Schmutz I, Korganow AS; DEFI study group.

J Clin Immunol. 2017 Oct;37(7):715-726. doi: 10.1007/s10875-017-0434-2. Epub 2017 Aug 26.

PMID:
28842786
2.

[Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome].

Fischer A, Hacein-Bey-Abina S, Lagresle C, Garrigue A, Cavazana-Calvo M.

Bull Acad Natl Med. 2005 May;189(5):779-85; discussion 786-8. French.

PMID:
16433450
3.

Gene therapy for severe combined immunodeficiency.

Cavazzana-Calvo M, Lagresle C, Hacein-Bey-Abina S, Fischer A.

Annu Rev Med. 2005;56:585-602. Review.

PMID:
15660528
4.

Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial.

Schmidt M, Hacein-Bey-Abina S, Wissler M, Carlier F, Lim A, Prinz C, Glimm H, Andre-Schmutz I, Hue C, Garrigue A, Le Deist F, Lagresle C, Fischer A, Cavazzana-Calvo M, von Kalle C.

Blood. 2005 Apr 1;105(7):2699-706. Epub 2004 Dec 7.

PMID:
15585650
5.

[The bone marrow: a reserve of stem cells able to repair various tissues?].

Cavazzana-Calvo M, Lagresle C, André-Schmutz I, Hacein-Bey-Abina S.

Ann Biol Clin (Paris). 2004 Mar-Apr;62(2):131-8. Review. French.

6.

Disruption of the lineage restriction of TCR beta gene rearrangements.

Eyquem S, Lagresle C, Fasseu M, Sigaux F, Bories JC.

Eur J Immunol. 2002 Nov;32(11):3256-66.

7.

Medical perspectives of adults and embryonic stem cells.

Cavazzana-Calvo M, André-Schmutz I, Lagresle C, Fischer A.

C R Biol. 2002 Oct;325(10):1053-8.

PMID:
12494504
8.

Transgenic expression of the p16(INK4a) cyclin-dependent kinase inhibitor leads to enhanced apoptosis and differentiation arrest of CD4-CD8- immature thymocytes.

Lagresle C, Gardie B, Eyquem S, Fasseu M, Vieville JC, Pla M, Sigaux F, Bories JC.

J Immunol. 2002 Mar 1;168(5):2325-31.

9.

Fas-dependent and Fas-independent mechanisms for selection of the mature human B cell repertoire.

Defrance T, Billian G, Krammer PH, Lagresle C.

Ann N Y Acad Sci. 1997 Apr 5;815:67-74. Review. No abstract available.

PMID:
9186640
10.

Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis.

Lagresle C, Mondière P, Bella C, Krammer PH, Defrance T.

J Exp Med. 1996 Apr 1;183(4):1377-88.

11.

The differentiation of human memory B cells into specific antibody-secreting cells is CD40 independent.

Silvy A, Lagresle C, Bella C, Defrance T.

Eur J Immunol. 1996 Mar;26(3):517-24.

PMID:
8605915
12.

Regulation of germinal center B cell differentiation. Role of the human APO-1/Fas (CD95) molecule.

Lagresle C, Bella C, Daniel PT, Krammer PH, Defrance T.

J Immunol. 1995 Jun 1;154(11):5746-56.

PMID:
7538529
13.

Towards identification of memory B cells in human tonsils.

Defrance T, Lagresle C.

Adv Exp Med Biol. 1994;355:33-8. No abstract available.

PMID:
7709841
14.

Supplemental Content

Loading ...
Support Center